What Is Lipoprotein(a) and Why It Matters for Heart Health
Share
Heart disease remains one of the leading causes of death worldwide. A large portion of these deaths come from conditions such as heart attacks, strokes, and blocked arteries. In recent years, researchers have identified an important blood marker that may increase the risk of these conditions. This marker is called Lipoprotein(a), often written as Lp(a).
Lp(a) is a type of cholesterol particle that is similar to LDL cholesterol, which many people know as “bad cholesterol.” However, Lp(a) has an extra protein attached to it called apolipoprotein(a). This extra component makes it behave differently in the body and can increase the risk of cardiovascular disease.
Many experts now consider high Lp(a) levels an independent risk factor for heart disease. That means even if other cholesterol numbers look normal, a high Lp(a) level may still increase risk.
Why High Lp(a) Levels Can Be Harmful
Lp(a) can increase heart disease risk in several ways. First, it contributes to the buildup of fatty deposits inside blood vessels. Over time, these deposits can narrow the arteries and reduce blood flow to the heart and brain.
Second, Lp(a) may promote blood clot formation. The structure of apolipoprotein(a) is similar to a protein involved in clot breakdown. Because of this similarity, Lp(a) can interfere with the body’s ability to dissolve clots effectively. This can increase the risk of heart attacks and strokes.
Third, Lp(a) carries inflammatory molecules called oxidized phospholipids. These molecules can damage the inner lining of blood vessels and accelerate the development of atherosclerosis, which is the hardening and narrowing of arteries.
What Research Shows About Lp(a) and Heart Disease
Large population studies have helped scientists understand how Lp(a) affects heart disease risk. In one analysis of more than 350,000 people from the UK Biobank, researchers found that higher Lp(a) levels were linked to a higher risk of cardiovascular disease.
People with Lp(a) levels in the highest group had about a 25 percent higher risk of developing atherosclerotic cardiovascular disease compared with those in the lowest group.
The study also found that every small increase in Lp(a) raised risk slightly. For example, each increase of 10 nmol/L in Lp(a) was associated with about a 2 percent increase in cardiovascular disease risk.
These results suggest that the relationship between Lp(a) and heart disease is gradual. Risk increases as levels rise, especially at very high concentrations.
Why Lifestyle Changes May Not Lower Lp(a) Much
One challenge with Lp(a) is that it is largely controlled by genetics. Studies show that genetic variations explain around 70 to 90 percent of the differences in Lp(a) levels between individuals.
Because of this strong genetic influence, common lifestyle changes such as diet, exercise, and weight loss usually have only a small effect on Lp(a) levels.
That does not mean healthy habits are useless. They still reduce overall cardiovascular risk by improving blood pressure, lowering LDL cholesterol, and controlling blood sugar. However, these changes may not dramatically reduce Lp(a) itself.
When Should You Get Tested for Lp(a)?
Many experts now recommend checking Lp(a) at least once in a lifetime, especially for people with certain risk factors. These include:
Family history of early heart disease
High cholesterol that does not respond well to treatment
Unexplained heart attacks or strokes
Strong family history of elevated Lp(a)
Testing is done through a simple blood test. Since Lp(a) levels are genetically determined and usually stable throughout life, most people only need to test once.
Current and Future Treatments
Traditional cholesterol medications do not significantly lower Lp(a). In fact, some statins may slightly increase Lp(a) levels, although they still reduce overall heart risk by lowering LDL cholesterol.
For people with extremely high Lp(a), a procedure called lipoprotein apheresis can reduce levels by filtering the blood. However, this treatment is expensive and requires regular sessions.
Researchers are currently developing new treatments that directly target Lp(a). These include gene silencing therapies such as antisense oligonucleotides and small interfering RNA. Early clinical trials suggest these treatments may reduce Lp(a) levels by 80 to 90 percent.
If these therapies prove safe and effective in larger studies, they could become an important tool for reducing cardiovascular risk in people with very high Lp(a).
Practical Steps to Protect Your Heart
Even though Lp(a) is largely genetic, there are still many ways to reduce overall heart disease risk.
First, manage traditional risk factors. Keep LDL cholesterol, blood pressure, and blood sugar under control.
Second, follow a heart healthy diet rich in fruits, vegetables, whole grains, and healthy fats.
Third, stay physically active and avoid smoking.
Finally, speak with your doctor about whether Lp(a) testing is appropriate for you, especially if heart disease runs in your family.
Understanding Lp(a) can help identify hidden cardiovascular risk and guide better prevention strategies. As research continues and new treatments become available, managing this genetic risk factor may become an important part of heart health in the future.